Tenaya Therapeutics

TNYA

Insider trades and stock quote 2024-2026

All insider trades at Tenaya Therapeutics

Subscribe RSS
Date Type Insider Position Ø-Price Volume
8/17/2026 Sell Tingley, Whittemore Chief Medical Officer $0.7 $5,270
8/17/2026 Sell Ali, Faraz Chief Executive Officer $0.7 $15,779
5/18/2026 Sell Higa, Tomohiro SVP, Finance $0.8 $1,178
5/18/2026 Sell Tingley, Whittemore Chief Medical Officer $0.8 $2,477
5/18/2026 Sell Ali, Faraz Chief Executive Officer $0.8 $2,690
2/25/2026 Sell Column Group III Gp, Lp Ten Percent Owner $0.6 $1,975,051
2/24/2026 Sell Column Group III Gp, Lp Ten Percent Owner $0.6 $405,138
2/23/2026 Sell Column Group III Gp, Lp Ten Percent Owner $0.6 $182,743
2/20/2026 Sell Column Group III Gp, Lp Ten Percent Owner $0.6 $322,044
2/17/2026 Sell Tingley, Whittemore Chief Medical Officer $0.6 $3,318
2/17/2026 Sell Ali, Faraz Chief Executive Officer $0.6 $9,557
2/17/2026 Sell Higa, Tomohiro SVP, Finance $0.6 $2,231
2/11/2026 Sell Column Group III Gp, Lp Ten Percent Owner $0.7 $2,761,715
2/10/2026 Sell Column Group III Gp, Lp Ten Percent Owner $0.8 $280,507
11/17/2025 Sell Ali, Faraz Chief Executive Officer $1.3 $4,158
11/17/2025 Sell Tingley, Whittemore Chief Medical Officer $1.3 $3,826
11/17/2025 Sell Higa, Tomohiro SVP, Finance $1.3 $1,818
8/18/2025 Sell Higa, Tomohiro SVP, Finance $1.2 $3,711
8/18/2025 Sell Ali, Faraz Chief Executive Officer $1.2 $18,210
8/18/2025 Sell Tingley, Whittemore Chief Medical Officer $1.2 $6,332
5/16/2025 Sell Ali, Faraz Chief Executive Officer $0.4 $1,412
5/16/2025 Sell Tingley, Whittemore Chief Medical Officer $0.4 $1,300
5/16/2025 Sell Higa, Tomohiro SVP, Finance $0.4 $615
3/10/2025 Sell Ali, Faraz Chief Executive Officer $0.5 $5,244
3/10/2025 Sell Tingley, Whittemore Chief Medical Officer $0.5 $3,983
3/10/2025 Sell Higa, Tomohiro SVP, Finance $0.5 $1,337
3/5/2025 Buy Goeddel, David V. Director $0.7 $24,999,999
3/5/2025 Buy Column Group III Gp, Lp Ten Percent Owner $0.7 $24,999,999
11/18/2024 Sell Saito, Chihiro SVP, Accounting and Fin. Ops. $2.1 $4,787
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)